Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C097240 |
15-deoxy-delta(12,14)-prostaglandin J2 |
[15-deoxy-delta(12,14)-prostaglandin J2 co-treated with alitretinoin] results in decreased phosphorylation of MTOR protein | affects cotreatment|decreases phosphorylation | 16611854
|
C027576 |
4-hydroxy-2-nonenal |
4-hydroxy-2-nonenal results in decreased expression of MTOR mRNA | decreases expression | 12419474
|
C065250 |
4-hydroxy-equilenin |
4-hydroxy-equilenin results in decreased expression of MTOR mRNA | decreases expression | 15135645
|
C103303 |
alitretinoin |
[15-deoxy-delta(12,14)-prostaglandin J2 co-treated with alitretinoin] results in decreased phosphorylation of MTOR protein | affects cotreatment|decreases phosphorylation | 16611854
|
D000638 |
Amiodarone |
Amiodarone inhibits the reaction [MTOR protein results in increased phosphorylation of EIF4EBP1 protein] | decreases reaction|increases phosphorylation | 19771169
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of MTOR mRNA | affects expression | 16483693
|
D000735 |
Androstenedione |
Androstenedione affects the activity of MTOR protein | affects activity | 16033851
|
D000735 |
Androstenedione |
everolimus inhibits the reaction [Androstenedione affects the activity of MTOR protein] | affects activity|decreases reaction | 16033851
|
D000735 |
Androstenedione |
[letrozole co-treated with everolimus] inhibits the reaction [Androstenedione affects the activity of MTOR protein] | affects activity|affects cotreatment|decreases reaction | 16033851
|
D000735 |
Androstenedione |
letrozole inhibits the reaction [Androstenedione affects the activity of MTOR protein] | affects activity|decreases reaction | 16033851
|
D020001 |
1-Butanol |
1-Butanol affects the activity of MTOR protein | affects activity | 16537399
|
D002118 |
Calcium |
Calcium affects the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of MTOR protein] | affects reaction|increases activity|increases phosphorylation | 12935885
|
C107676 |
deguelin |
deguelin metabolite results in decreased expression of MTOR protein | decreases expression | 19139008
|
C107676 |
deguelin |
deguelin results in decreased expression of MTOR protein | decreases expression | 19139008
|
D004958 |
Estradiol |
Estradiol affects the activity of MTOR protein | affects activity | 16033851
|
D004958 |
Estradiol |
Estradiol results in increased activity of MTOR protein | increases activity | 16024245
|
D004958 |
Estradiol |
everolimus inhibits the reaction [Estradiol affects the activity of MTOR protein] | affects activity|decreases reaction | 16033851
|
D004958 |
Estradiol |
letrozole inhibits the reaction [Estradiol affects the activity of MTOR protein] | affects activity|decreases reaction | 16033851
|
D000431 |
Ethanol |
Ethanol inhibits the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of MTOR protein] | decreases reaction|increases activity|increases phosphorylation | 12935885
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of MTOR mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of MTOR mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MTOR mRNA | affects cotreatment|increases expression | 17942748
|
D005038 |
Ethylnitrosourea |
Ethylnitrosourea results in increased mutagenesis of MTOR gene | increases mutagenesis | 15485918 16724327
|
C107135 |
everolimus |
everolimus inhibits the reaction [Androstenedione affects the activity of MTOR protein] | affects activity|decreases reaction | 16033851
|
C107135 |
everolimus |
everolimus inhibits the reaction [Estradiol affects the activity of MTOR protein] | affects activity|decreases reaction | 16033851
|
C107135 |
everolimus |
everolimus results in decreased activity of MTOR protein | decreases activity | 16033851
|
C107135 |
everolimus |
[letrozole co-treated with everolimus] inhibits the reaction [Androstenedione affects the activity of MTOR protein] | affects activity|affects cotreatment|decreases reaction | 16033851
|
D006581 |
Hexachlorobenzene |
Hexachlorobenzene results in decreased expression of MTOR mRNA | decreases expression | 15159207
|
D004441 |
Ecdysterone |
Ecdysterone results in decreased expression of MTOR mRNA | decreases expression | 15776001
|
C097613 |
imatinib |
imatinib promotes the reaction [NVP ADW742 inhibits the reaction [IGF1 protein results in increased phosphorylation of MTOR protein]] | decreases reaction|increases phosphorylation|increases reaction | 16740780
|
C097613 |
imatinib |
imatinib results in decreased expression of MTOR protein | decreases expression | 19208803
|
C097613 |
imatinib |
tetraarsenic tetrasulfide promotes the reaction [imatinib results in decreased expression of MTOR protein] | decreases expression|increases reaction | 19208803
|
C067431 |
letrozole |
[letrozole co-treated with everolimus] inhibits the reaction [Androstenedione affects the activity of MTOR protein] | affects activity|affects cotreatment|decreases reaction | 16033851
|
C067431 |
letrozole |
letrozole inhibits the reaction [Androstenedione affects the activity of MTOR protein] | affects activity|decreases reaction | 16033851
|
C067431 |
letrozole |
letrozole inhibits the reaction [Estradiol affects the activity of MTOR protein] | affects activity|decreases reaction | 16033851
|
C032881 |
lysophosphatidic acid |
lysophosphatidic acid results in increased phosphorylation of MTOR protein | increases phosphorylation | 14769825
|
D008345 |
Manganese |
Manganese results in decreased phosphorylation of MTOR protein | decreases phosphorylation | 17043766
|
D008345 |
Manganese |
Manganese results in increased phosphorylation of MTOR protein | increases phosphorylation | 17043766
|
D009534 |
Niclosamide |
Niclosamide inhibits the reaction [MTOR protein results in increased phosphorylation of EIF4EBP1 protein] | decreases reaction|increases phosphorylation | 19771169
|
C502355 |
NVP ADW742 |
imatinib promotes the reaction [NVP ADW742 inhibits the reaction [IGF1 protein results in increased phosphorylation of MTOR protein]] | decreases reaction|increases phosphorylation|increases reaction | 16740780
|
C502355 |
NVP ADW742 |
NVP ADW742 inhibits the reaction [IGF1 protein results in increased phosphorylation of MTOR protein] | decreases reaction|increases phosphorylation | 16740780
|
C030110 |
oxaliplatin |
oxaliplatin results in increased phosphorylation of MTOR protein | increases phosphorylation | 19147571
|
D010269 |
Paraquat |
Paraquat results in decreased phosphorylation of MTOR protein | decreases phosphorylation | 17341480
|
D010480 |
Perhexiline |
Perhexiline inhibits the reaction [MTOR protein results in increased phosphorylation of EIF4EBP1 protein] | decreases reaction|increases phosphorylation | 19771169
|
D010656 |
Phenylephrine |
Phenylephrine results in increased phosphorylation of MTOR protein | increases phosphorylation | 17976640
|
D010656 |
Phenylephrine |
wortmannin inhibits the reaction [Phenylephrine results in increased phosphorylation of MTOR protein] | decreases reaction|increases phosphorylation | 17976640
|
D010656 |
Phenylephrine |
Calcium affects the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of MTOR protein] | affects reaction|increases activity|increases phosphorylation | 12935885
|
D010656 |
Phenylephrine |
Ethanol inhibits the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of MTOR protein] | decreases reaction|increases activity|increases phosphorylation | 12935885
|
D010656 |
Phenylephrine |
[Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of MTOR protein | increases activity|increases phosphorylation | 12935885
|
D010712 |
Phosphatidic Acids |
Phosphatidic Acids results in increased phosphorylation of MTOR protein | increases phosphorylation | 18621911
|
D010712 |
Phosphatidic Acids |
[Phosphatidic Acids results in increased phosphorylation of MTOR protein] which results in increased phosphorylation of RPS6KB1 protein | increases phosphorylation | 18621911
|
D010712 |
Phosphatidic Acids |
[Phosphatidic Acids results in increased phosphorylation of MTOR protein] which results in increased phosphorylation of RPS6 protein | increases phosphorylation | 18621911
|
D010712 |
Phosphatidic Acids |
MTOR protein affects the reaction [Phosphatidic Acids results in increased activity of RPS6KB2 protein] | affects reaction|increases activity | 12087098
|
D010712 |
Phosphatidic Acids |
Phosphatidic Acids results in increased activity of MTOR protein | increases activity | 16537399
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of MTOR mRNA | increases expression | 18301758
|
D017035 |
Pravastatin |
Pravastatin results in increased phosphorylation of MTOR protein | increases phosphorylation | 15625077
|
C059514 |
resveratrol |
resveratrol results in increased expression of MTOR mRNA | increases expression | 12002526
|
C085746 |
rottlerin |
rottlerin inhibits the reaction [MTOR protein results in increased phosphorylation of EIF4EBP1 protein] | decreases reaction|increases phosphorylation | 19771169
|
D020123 |
Sirolimus |
MTOR protein inhibits the reaction [Sirolimus results in decreased activity of RPS6KB2 protein] | decreases activity|decreases reaction | 12087098
|
D020123 |
Sirolimus |
Sirolimus results in decreased activity of MTOR mRNA | decreases activity | 17996122
|
D020123 |
Sirolimus |
Sirolimus results in decreased activity of MTOR protein | decreases activity | 15782132 15050414
|
D020123 |
Sirolimus |
[Sirolimus results in decreased activity of MTOR protein] inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | decreases activity|decreases reaction|increases activity|increases phosphorylation | 15919668
|
D020123 |
Sirolimus |
Sirolimus results in decreased activity of MTOR protein | decreases activity | 17510244
|
D013629 |
Tamoxifen |
Tamoxifen results in decreased activity of MTOR protein | decreases activity | 19931998
|
D013629 |
Tamoxifen |
[Tamoxifen results in decreased activity of MTOR protein] which results in decreased phosphorylation of RPS6KB1 protein | decreases activity|decreases phosphorylation | 19931998
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of MTOR mRNA | affects expression | 17555576
|
C401859 |
temsirolimus |
temsirolimus results in decreased activity of MTOR protein | decreases activity | 16033649
|
C401859 |
temsirolimus |
temsirolimus results in decreased activity of MTOR protein | decreases activity | 16954435
|
C534735 |
tetraarsenic tetrasulfide |
tetraarsenic tetrasulfide promotes the reaction [imatinib results in decreased expression of MTOR protein] | decreases expression|increases reaction | 19208803
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MTOR mRNA | affects cotreatment|increases expression | 17942748
|
D013755 |
Tetradecanoylphorbol Acetate |
RAF1 protein affects the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MTOR protein] | affects reaction|increases phosphorylation | 17976640
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in increased phosphorylation of MTOR protein | increases phosphorylation | 17976640
|
C009687 |
wortmannin |
wortmannin inhibits the reaction [Phenylephrine results in increased phosphorylation of MTOR protein] | decreases reaction|increases phosphorylation | 17976640
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.13 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
7.13 | 18926900 17676605 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.13 | 11752688 15322242 14514962 |
MESH:D000015 |
Abnormalities, Multiple |
|
imatinib |
4.89 | 18322153 |
MESH:D000022 |
Abortion, Spontaneous |
|
imatinib |
5.80 | 18322153 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
9.12 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
9.12 | 11192467 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.53 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.49 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.75 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
3.83 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
3.83 | 14692618 |
MESH:D000236 |
Adenoma |
|
Ethylnitrosourea |
6.39 | 6695378 |
MESH:D000236 |
Adenoma |
|
resveratrol |
6.39 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
8.55 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
8.55 | 16835633 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Paraquat |
3.37 | 11874814 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
4.90 | 15451039 15451040 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.48 | 16162502 16183991 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
4-hydroxy-2-nonenal |
3.84 | 10965797 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.60 | 11748828 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Manganese |
4.50 | 16910769 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.42 | 15513904 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
3.68 | 11141031 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Amiodarone |
7.98 | 18218290 18057881 20041841 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
7.98 | 17460149 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.07 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
6.51 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
6.51 | 17115116 |
MESH:D001259 |
Ataxia |
|
1-Butanol |
5.21 | 7820390 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.03 | 17967414 16873680 |
MESH:D001281 |
Atrial Fibrillation |
|
Amiodarone |
3.60 | 18651412 19698954 |
MESH:D001321 |
Autistic Disorder |
|
Sirolimus |
3.25 | 21115397 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Amiodarone |
13.21 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
13.21 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
13.21 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.38 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.50 | 15746008 |
MESH:D001859 |
Bone Neoplasms |
|
imatinib |
4.95 | 15867366 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
4.14 | 15306635 |
MESH:D001927 |
Brain Diseases |
|
Ethylnitrosourea |
4.53 | 14991843 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
3.88 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Ethylnitrosourea |
3.94 | 18412241 16651633 16357521 15144691 16436596 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
6.48 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
deguelin |
6.48 | 17035597 18593368 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
6.48 | 17289903 17018787 12948864 17261762 19861407 14630087 16675129 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
Hexachlorobenzene |
6.48 | 12709520 15061365 |
MESH:D001943 |
Breast Neoplasms |
|
imatinib |
6.48 | 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
letrozole |
6.48 | 16002280 17892469 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
6.48 | 17651959 16393696 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
6.48 | 19142967 17440819 21138602 18629630 16202921 20544844 19410462 21152245 18984771 19155303 16273361 20135344 19059307 20859285 16873071 11161223 19289846 19200415 17242785 19189212 18425577 15668708 20005174 18815881 17049068 15565566 19288272 18351453 19487384 19189210 16818667 18855134 20390343 19221464 19244106 19115204 19103187 19011961 19066611 17893378 20065188 19084267 17261762 18997820 18821012 |
MESH:D001943 |
Breast Neoplasms |
|
temsirolimus |
6.48 | 16954435 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
6.48 | 20435547 |
MESH:D002056 |
Burns |
|
Ethanol |
4.26 | 16374292 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.06 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.48 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.11 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
deguelin |
10.39 | 18575727 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
10.39 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
10.39 | 18788625 15763234 15289165 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
10.39 | 16227395 19321006 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Sirolimus |
10.39 | 19335982 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
10.39 | 16924424 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.19 | 16675471 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
7.07 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Sirolimus |
7.07 | 19435901 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
7.07 | 18922899 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.26 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
10.14 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
10.14 | 15728586 11754973 17124262 17287366 16170337 11179087 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
10.14 | 18850075 16120746 18670907 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Amiodarone |
2.74 | 19225199 15710769 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
3.19 | 15458977 |
MESH:D002341 |
Carotid Artery Thrombosis |
|
Amiodarone |
4.68 | 18974383 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.08 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Ethylnitrosourea |
6.08 | 16003739 |
MESH:D016543 |
Central Nervous System Neoplasms |
|
Ethylnitrosourea |
5.57 | 17160924 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Androstenedione |
4.44 | 21398041 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.82 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
6.74 | 15861022 16919318 17110522 17681005 11677210 16105132 17333356 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
6.74 | 19176532 |
MESH:D016770 |
Ciliophora Infections |
|
Niclosamide |
5.32 | 12113305 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
3.37 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
5.35 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.35 | 16354765 8697196 15340226 12621046 15668235 |
MESH:D003092 |
Colitis |
|
resveratrol |
3.73 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
oxaliplatin |
3.97 | 16004971 16510598 16024531 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
3.97 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
oxaliplatin |
2.91 | 18509181 17255274 17695437 17594712 17401013 18448328 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.91 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.72 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.49 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
3.72 | 15451039 15513904 19302082 15451040 10194807 11198716 11873399 |
MESH:D019465 |
Craniofacial Abnormalities |
|
imatinib |
3.72 | 18322153 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.72 | 20055451 10048152 15322242 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.96 | 19031437 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.23 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.44 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.56 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
13.05 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
13.05 | 16286809 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
13.05 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Amiodarone |
5.53 | 18218290 15265979 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
5.53 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
5.53 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.46 | 11462148 |
MESH:D004476 |
Ectodermal Dysplasia |
|
Ethylnitrosourea |
5.57 | 18357618 |
MESH:D004487 |
Edema |
|
imatinib |
17.86 | 19703484 |
MESH:D004487 |
Edema |
|
pirinixic acid |
17.86 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
17.86 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
17.86 | 11000095 12711302 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
17.86 | 7812673 15177302 8273558 16716910 8113982 9599246 11698051 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.49 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
15-deoxy-delta(12,14)-prostaglandin J2 |
18.82 | 16844232 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
18.82 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
18.82 | 17872969 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
18.82 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
6.49 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
6.49 | 16202921 19155303 20544844 17893378 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.67 | 10568697 9294722 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.45 | 17923197 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
2.65 | 16704527 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.71 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Amiodarone |
20.81 | 14986274 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
20.81 | 19236843 16409862 18620774 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
20.81 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
20.81 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
20.81 | 14986274 19224547 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.25 | 17920746 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
2.98 | 16709447 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
4.89 | 16946407 15451040 10194807 15513904 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.06 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.12 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
imatinib |
10.48 | 17453242 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
10.48 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.56 | 20067830 |
MESH:D005393 |
Fish Diseases |
|
Niclosamide |
5.28 | 12113305 |
MESH:D005756 |
Gastritis |
|
Ethanol |
4.28 | 15046732 |
MESH:D005909 |
Glioblastoma |
|
Ethylnitrosourea |
6.86 | 16436596 |
MESH:D005909 |
Glioblastoma |
|
Manganese |
6.86 | 17043766 |
MESH:D005910 |
Glioma |
|
Ethylnitrosourea |
3.32 | 16357521 18412241 16651633 |
MESH:D005911 |
Gliosis |
|
Paraquat |
4.75 | 11124998 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.18 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Sirolimus |
4.19 | 19435901 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.11 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.28 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.97 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Amiodarone |
12.12 | 15265979 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
12.12 | 19772884 16221962 18467677 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
12.12 | 16120746 12621046 15340226 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.62 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.78 | 16876885 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.34 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.63 | 16959395 15340226 16354765 8697196 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
7.36 | 18783367 |
MESH:D006930 |
Hyperalgesia |
|
oxaliplatin |
7.36 | 17418472 |
MESH:D006937 |
Hypercholesterolemia |
|
Amiodarone |
13.49 | 8137927 9751232 |
MESH:D006937 |
Hypercholesterolemia |
|
Pravastatin |
13.49 | 17188708 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
13.49 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.83 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.66 | 16873680 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
4.75 | 8949925 12717712 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.75 | 18670907 18850075 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
9.80 | 12791704 18502941 |
MESH:D006984 |
Hypertrophy |
|
Sirolimus |
9.80 | 19211884 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.95 | 17488730 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.41 | 16945680 16569931 |
MESH:D007037 |
Hypothyroidism |
|
Amiodarone |
4.12 | 17991464 18020914 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.25 | 17600658 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.09 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
5.83 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
Paraquat |
5.83 | 4850670 |
MESH:D007249 |
Inflammation |
|
resveratrol |
10.18 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
10.18 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
10.18 | 12200463 12878042 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
10.18 | 15177302 7812673 11698051 8273558 7562506 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.13 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.30 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.30 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
8.91 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.91 | 16580747 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
5.23 | 16144296 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.35 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
10.64 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Ethylnitrosourea |
10.64 | 17379185 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
10.64 | 18625569 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
4.63 | 16316344 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
3.82 | 15451040 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
imatinib |
8.46 | 15107311 19208803 17301526 15748426 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
tetraarsenic tetrasulfide |
8.46 | 19208803 |
MESH:D007951 |
Leukemia, Myeloid |
|
imatinib |
4.74 | 17236224 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.31 | 16087638 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
3.52 | 17676605 |
MESH:D008064 |
Lipidoses |
|
Amiodarone |
11.71 | 15342952 17567588 |
MESH:D008064 |
Lipidoses |
|
Perhexiline |
11.71 | 17567588 15342952 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
11.71 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
3.14 | 15289165 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.69 | 18295389 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
9.98 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
9.98 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
imatinib |
9.98 | 16596278 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
9.98 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Sirolimus |
9.98 | 17050028 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
9.98 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
9.98 | 12878042 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
4.26 | 17347304 17207112 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
9.31 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
9.31 | 20405173 19812893 19321006 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
9.31 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
9.31 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Hexachlorobenzene |
5.33 | 1423854 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.33 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
Amiodarone |
3.27 | 11989578 15350150 17391786 |
MESH:D008171 |
Lung Diseases |
|
Amiodarone |
3.10 | 12587719 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Amiodarone |
4.07 | 18516814 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
7.80 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
deguelin |
7.80 | 16288123 19336726 |
MESH:D008175 |
Lung Neoplasms |
|
Ethylnitrosourea |
7.80 | 6695378 16019985 17703301 16271038 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
7.80 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
7.80 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
7.80 | 11807781 |
MESH:D008223 |
Lymphoma |
|
Ethylnitrosourea |
3.65 | 15790496 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
3.93 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.54 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Ethylnitrosourea |
4.65 | 15375218 |
MESH:D016778 |
Malaria, Falciparum |
|
Perhexiline |
5.57 | 16882315 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
8.65 | 15688416 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
8.65 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
16.03 | 11408345 11807958 16891317 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylnitrosourea |
16.03 | 10767621 18041768 10838139 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
16.03 | 11606380 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
16.03 | 16827153 14580682 19196722 11731420 19196723 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
16.03 | 8985016 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
19.99 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Manganese |
19.99 | 16568477 19453300 16551646 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
19.99 | 19453300 |
MESH:D008545 |
Melanoma |
|
resveratrol |
6.78 | 17992120 |
MESH:D008545 |
Melanoma |
|
Sirolimus |
6.78 | 19282848 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
6.78 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
temsirolimus |
6.78 | 17508024 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.78 | 15990972 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
3.80 | 15451040 18411066 |
MESH:D008579 |
Meningioma |
|
Ethylnitrosourea |
5.57 | 17943659 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.01 | 17112576 |
MESH:D009062 |
Mouth Neoplasms |
|
Sirolimus |
4.40 | 19435901 |
MESH:D009069 |
Movement Disorders |
|
Manganese |
4.64 | 16551646 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
3.18 | 16267019 17049120 17164350 14749477 17935668 16490592 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.46 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.11 | 16239165 |
MESH:D009181 |
Mycoses |
|
Amiodarone |
4.49 | 12754197 17974566 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
8.65 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
Pravastatin |
8.65 | 17188708 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
8.65 | 17188708 16456233 17125593 16317513 16525036 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
7.94 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
7.94 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.22 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.22 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.35 | 17322642 |
MESH:D009362 |
Neoplasm Metastasis |
|
imatinib |
5.68 | 15867366 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.68 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.37 | 19410462 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
7.33 | 16946489 |
MESH:D009369 |
Neoplasms |
|
deguelin |
7.33 | 17764071 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
7.33 | 17405874 |
MESH:D009374 |
Neoplasms, Experimental |
|
Ethylnitrosourea |
8.18 | 16707424 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
8.18 | 8985016 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
imatinib |
9.80 | 17614352 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
9.80 | 19200415 19189210 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.33 | 17289903 |
MESH:D009410 |
Nerve Degeneration |
|
Manganese |
7.75 | 16551646 |
MESH:D009410 |
Nerve Degeneration |
|
Paraquat |
7.75 | 16893418 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
8.18 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.18 | 14600291 |
MESH:D009442 |
Neurilemmoma |
|
Ethylnitrosourea |
5.01 | 17160924 16651423 16003739 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
3.48 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.02 | 17929310 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.71 | 20558911 |
MESH:D009837 |
Oligodendroglioma |
|
Ethylnitrosourea |
5.57 | 17160924 |
MESH:D010014 |
Osteolysis |
|
imatinib |
5.33 | 15867366 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
3.53 | 17882678 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
3.88 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.09 | 19401270 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
5.17 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
5.17 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.31 | 11578682 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
3.90 | 18922899 18404319 12065085 8330346 |
MESH:D010300 |
Parkinson Disease |
|
Manganese |
7.98 | 11181820 |
MESH:D010300 |
Parkinson Disease |
|
Paraquat |
7.98 | 12911755 11124998 11445065 15451049 16510128 16140633 11181820 15824117 |
MESH:D010300 |
Parkinson Disease |
|
Sirolimus |
7.98 | 19682553 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Paraquat |
4.03 | 16190885 |
MESH:D020734 |
Parkinsonian Disorders |
|
Manganese |
4.12 | 16140633 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.83 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4-hydroxy-2-nonenal |
5.09 | 11550810 |
MESH:D011014 |
Pneumonia |
|
Paraquat |
4.05 | 12504350 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
5.59 | 16144296 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Hexachlorobenzene |
9.82 | 9918132 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
9.82 | 18163543 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
imatinib |
4.25 | 12476293 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
8.24 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.24 | 11896295 11118676 11399792 11222880 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.52 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.73 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.73 | 16731767 17804756 17718901 17636462 17675339 15767336 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.73 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.91 | 16919318 15861022 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Amiodarone |
5.28 | 12832656 12490602 11597910 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Paraquat |
5.28 | 16324872 17997886 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.17 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
5.88 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
5.88 | 16317513 16314181 15827377 17520802 17058453 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Paraquat |
3.53 | 11700416 |
MESH:D012135 |
Respiratory Sounds |
|
Paraquat |
3.66 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.45 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Paraquat |
3.56 | 16458197 |
MESH:D012512 |
Sarcoma, Ewing's |
|
NVP ADW742 |
6.07 | 16740780 |
MESH:D012640 |
Seizures |
|
Ethanol |
2.91 | 9754883 |
OMIM:609620 |
SHORT QT SYNDROME 1 |
|
Amiodarone |
4.68 | 18724381 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.30 | 7327846 |
MESH:D012878 |
Skin Neoplasms |
|
deguelin |
12.02 | 16041863 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
12.02 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
12.02 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
12.02 | 18404319 8985016 8330346 11807781 12065085 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.18 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.18 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.63 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
3.02 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
imatinib |
3.02 | 15786421 |
MESH:D013276 |
Stomach Ulcer |
|
Amiodarone |
6.30 | 18087811 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
6.30 | 17189318 11906479 9562338 17918041 16755016 9211565 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.13 | 16321402 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
3.90 | 9754883 |
MESH:D013610 |
Tachycardia |
|
Amiodarone |
3.90 | 11238279 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Amiodarone |
3.80 | 19225199 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.25 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.81 | 15669648 |
MESH:D013953 |
Thymus Neoplasms |
|
Ethylnitrosourea |
4.75 | 15790496 |
MESH:D013959 |
Thyroid Diseases |
|
Amiodarone |
10.67 | 19731979 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
10.67 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
imatinib |
4.13 | 16940797 |
MESH:D013971 |
Thyrotoxicosis |
|
Amiodarone |
4.46 | 19584973 18020914 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.27 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
3.86 | 16227395 |
MESH:D016171 |
Torsades de Pointes |
|
Amiodarone |
3.79 | 11989578 17467628 |
MESH:D014402 |
Tuberous Sclerosis |
|
everolimus |
11.52 | 18495876 |
MESH:D014402 |
Tuberous Sclerosis |
|
Sirolimus |
11.52 | 18495876 21115397 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
2.20 | 8653321 16712894 17572228 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
3.75 | 17473185 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
8.22 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
8.22 | 17044934 |
MESH:D014605 |
Uveitis |
|
Sirolimus |
5.22 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.18 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.18 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
3.91 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.83 | 15886252 |
MESH:D014947 |
Wounds and Injuries |
|
lysophosphatidic acid |
4.98 | 15541073 |